Company Directory - The Lundquist Institute for Biomedical Innovation
Company Details - The Lundquist Institute for Biomedical Innovation
The Lundquist Institute for Biomedical Innovation
WebsiteThe Lundquist Institute for Biomedical Innovation is a research institute focused on advancing health studies and biomedical innovation. It collaborates with various partners to enhance healthcare outcomes through scientific research and development.
CCI Score
CCI Score: The Lundquist Institute for Biomedical Innovation
9.63
-0.01%
Latest Event
Graduate Workers Allege Misclassification at Lundquist Institute
At least three UCLA-affiliated graduate research workers have filed complaints alleging misclassification as independent contractors, leading to unpaid overtime, denied meal breaks, and lack of compliant wage statements at Harbor-UCLA Medical Center. The allegations suggest potential violations of labor rights under California law.
Take Action
So what can you do? Support by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
OBJECTOR
The Lundquist Institute for Biomedical Innovation is currently rated as an Objector.
Latest Events
- OCT042024
At least three UCLA-affiliated graduate research workers have filed complaints alleging misclassification as independent contractors, leading to unpaid overtime, denied meal breaks, and lack of compliant wage statements at Harbor-UCLA Medical Center. The allegations suggest potential violations of labor rights under California law.
-80
Labor Relations and Human Rights Practices
April 8
The allegations that the Lundquist Institute misclassified graduate research workers as independent contractors and underpaid them point to significant labor rights violations. This misclassification undermines fair wage practices and denies basic worker benefits, reflecting problematic business practices that exploit vulnerable workers.
UCLA Affiliate Graduate Student Workers Allege Misclassification
- APR242024
The Lundquist Institute for Biomedical Innovation has been awarded a four‐year grant of $2.6 million by the U.S. Army Medical Research Acquisition Activity to develop wearable biosensors aimed at early detection and management of COPD exacerbations.
+50
Business Practices and Ethical Responsibility
April 8
This event demonstrates ethical research practices in biomedical innovation. The institute’s commitment to advancing public health through improved chronic disease management is a positive corporate practice that benefits marginalized communities by reducing healthcare disparities.
+70
Technology and Services Impact
April 8
The development of innovative wearable biosensors positions the institute as a leader in biomedical technology. By advancing non-invasive monitoring techniques for chronic diseases, the research reinforces positive technological impact on healthcare, benefiting patient communities and promoting progressive medical practices.
- MAR262024
Congresswoman Nanette Barragán, alongside Lundquist Institute Interim President and CEO Marianne Gausche-Hill, celebrated the securing of approximately $469,000 in federal funding aimed at expanding bioscience research internships for underserved local undergraduate students, reinforcing community-based scientific innovation.
+60
Public and Political Behavior
April 8
The institute's involvement with a progressive elected official to secure federal funding underscores its commitment to public service and fostering equitable access to advanced research opportunities, bolstering democratic engagement.
+50
Economic and Structural Influence
April 8
The injection of federal funds is likely to enhance economic and structural development within healthcare research, driving local innovation and support for underserved populations, which aligns with progressive, community-focused economic policies.
Alternatives
Zug, Switzerland
22.95
Cambridge, United States
-13.08
Corporation
27.23
Corporation
0.00
Thousand Oaks, USA
13.63
Houston, United States
13.52
Foster City, USA
1.64
Seattle, United States
-23.78
Corporation
45.62
Corporation
11.88
Industries
- 541714
- Research and Development in Biotechnology (except Nanobiotechnology)
- 621511
- Medical Laboratories
- 541710
- Research and Development in the Physical, Engineering, and Life Sciences